Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The power of telemedicine to improve CAR-T cell therapy programs: lessons learned from COVID-19 pandemic.
Canale FA, Martino M, Porto G, Verduci C, Console G, Irrera G, Loteta B, Naso V, Pugliese M, Moscato T, Ferreri A, Nappi D, Nicolini F, Mazza M, Martinelli G, Cerchione C. Canale FA, et al. Among authors: cerchione c. Support Care Cancer. 2023 May 25;31(6):350. doi: 10.1007/s00520-023-07811-6. Support Care Cancer. 2023. PMID: 37227523 Free PMC article. Review.
A Frontline Approach With Peripherally Inserted Versus Centrally Inserted Central Venous Catheters for Remission Induction Chemotherapy Phase of Acute Myeloid Leukemia: A Randomized Comparison.
Picardi M, Della Pepa R, Cerchione C, Pugliese N, Mortaruolo C, Trastulli F, Giordano C, Grimaldi F, Zacheo I, Raimondo M, Chiurazzi F, Pane F. Picardi M, et al. Among authors: cerchione c. Clin Lymphoma Myeloma Leuk. 2019 Apr;19(4):e184-e194. doi: 10.1016/j.clml.2018.12.008. Epub 2018 Dec 20. Clin Lymphoma Myeloma Leuk. 2019. PMID: 30704933 Clinical Trial.
Ultrasonography-driven combination antibiotic therapy with tigecycline significantly increases survival among patients with neutropenic enterocolitis following cytarabine-containing chemotherapy for the remission induction of acute myeloid leukemia.
Pugliese N, Salvatore P, Iula DV, Catania MR, Chiurazzi F, Della Pepa R, Cerchione C, Raimondo M, Giordano C, Simeone L, Caruso S, Pane F, Picardi M. Pugliese N, et al. Among authors: cerchione c. Cancer Med. 2017 Jul;6(7):1500-1511. doi: 10.1002/cam4.1063. Epub 2017 May 26. Cancer Med. 2017. PMID: 28556623 Free PMC article.
Rituximab in a risk-adapted treatment strategy gives excellent therapeutic results in nodular lymphocyte-predominant Hodgkin lymphoma.
Della Pepa R, Picardi M, Giordano C, Zacheo I, Pugliese N, Cerchione C, Raimondo M, Di Perna M, Troncone G, Ciancia G, Intrieri M, Pane F. Della Pepa R, et al. Among authors: cerchione c. Br J Haematol. 2018 Sep;182(5):715-718. doi: 10.1111/bjh.14856. Epub 2017 Jul 24. Br J Haematol. 2018. PMID: 28737231 Free article. No abstract available.
The NLR and LMR ratio in newly diagnosed MM patients treated upfront with novel agents.
Romano A, Laura Parrinello N, Cerchione C, Letizia Consoli M, Parisi M, Calafiore V, Martino E, Conticello C, Di Raimondo F, Alberto Palumbo G. Romano A, et al. Among authors: cerchione c. Blood Cancer J. 2017 Dec 15;7(12):649. doi: 10.1038/s41408-017-0019-6. Blood Cancer J. 2017. PMID: 29242558 Free PMC article. No abstract available.
Randomized comparison of power Doppler ultrasonography-guided core-needle biopsy with open surgical biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma.
Pugliese N, Di Perna M, Cozzolino I, Ciancia G, Pettinato G, Zeppa P, Varone V, Masone S, Cerchione C, Della Pepa R, Simeone L, Giordano C, Martinelli V, Salvatore C, Pane F, Picardi M. Pugliese N, et al. Among authors: cerchione c. Ann Hematol. 2017 Apr;96(4):627-637. doi: 10.1007/s00277-017-2926-9. Epub 2017 Jan 27. Ann Hematol. 2017. PMID: 28130574 Free PMC article. Clinical Trial.
124 results